Heliospectra Q3 2024: Weaker gross margin, minor deviations elsewhere - Redeye

Redeye shares its initial comments on Heliospectra's Q3 results, noting that sales and cost base figures were roughly in line with estimates. However, the gross margin came in lower than expected due to the product mix. Nevertheless, these lower-margin orders are strategically important for Heliospectra and strengthen its negotiating position with component suppliers moving forward. Management remains optimistic about the outlook, observing high market activity.

Länk till analysen i sin helhet: https://www.redeye.se/research/1047330/heliospectra-q3-2024-weaker-gross-margin-minor-deviations-elsewhere?utm_source=finwire&utm_medium=RSS